1-2 of 2
Dali Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long term remission and survival in patients with relapsed or refractory non-Hodgkin lymphoma after treatment of brl-201, a CRISPR-based non-viral PD-1 locus specifically integrated anti-CD19 CAR-T cells: 4-year follow-up of a first-in-human phase I study

Free
Yongxian Hu, Qian Tan, Jiqin Zhang, Mingming Zhang, Wenjun Wu, Guoqing Wei, Binghe Tan, Jiazhen Cui, Yuxuan Wu, Dali Li, Bing Du, Mingyao Liu, He Huang
Journal: Blood
Blood (2025) 146 (Supplement 1): 5930.
https://doi.org/10.1182/blood-2025-5930
Published: 2025
Journal Articles

Efficacy and Safety of Brl-101, CRISPR-Cas9-Mediated Gene Editing of the BCL11A Enhancer in Transfusion-Dependent β-Thalassemia

Free
Biao Zheng, Rongrong Liu, Xinhua Zhang, Bin Fu, Yajing Xu, Jun Shi, Xiaoqin Feng, Li Wang, Chris Wang, Rongmei Liang, Lingzhi Tan, Fei Wang, Dali Li, Yuxuan Wu, Mingyao Liu, Yongrong Lai
Journal: Blood
Blood (2023) 142 (Supplement 1): 4995.
https://doi.org/10.1182/blood-2023-186031
Published: 2023